News
Zacks Investment Research on MSN7h
AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs OutperformAstraZeneca’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback